Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2025-12-25 @ 11:17 PM
NCT ID: NCT02815293
Description: Adverse Events reported for randomized patients only
Frequency Threshold: 5
Time Frame: Up to 223 days
Study: NCT02815293
Study Brief: Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AGN-195263 One drop of 0.1% AGN-195263 instilled in each eye twice daily 0 None 0 10 0 10 View
Vehicle One drop of AGN-195263 vehicle (placebo) instilled in each eye twice daily. 0 None 1 8 2 8 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Laceration SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Conjunctival haemorrhage SYSTEMATIC_ASSESSMENT Eye disorders MedDRA View
Eye irritation SYSTEMATIC_ASSESSMENT Eye disorders MedDRA View